AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ) soared at $0.25, representing a gain of 34.4%. On Wed, Oct 19, 2022, ANPC:NASDAQ hit a New 2-Week High of $0.25. The stock appeared on our News Catalysts scanner on Wed, Sep 28, 2022 at 09:57 AM in the 'INVESTOR UPDATE' category. From Wed, Oct 05, 2022, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Thu, Oct 13, 2022 at $0.33 with a volume of 48M+.
About AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ)
AnPac Bio-Medical Science Co Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative, patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated potential to assist physicians in cancer diagnosis, prognosis and recurrence.
Top 10 Gainers:
- Amprius Technologies Inc. (AMPX:NYSE), 77.29%
- Mullen Automotive Inc. (MULN:NASDAQ), 57.12%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 51.59%
- Creatd Inc. (CRTD:NASDAQ), 47.17%
- SenesTech, Inc. (SNES:NASDAQ), 46.55%
- RedHill Biopharma Ltd. (RDHL:NASDAQ), 46.55%
- Microvast Holdings Inc. (MVST:NASDAQ), 40.25%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 34.42%
- Cabaletta Bio, Inc. (CABA:NASDAQ), 31.13%
- HV Bancorp, Inc. (HVBC:NASDAQ), 27.43%